FDA Increases Warning Letter Campaign Against CBD Companies | Kaufman & Canoles
In November the Food and Drug Administration (FDA) issued letters to various companies selling products contained cannabidiol (CBD), citing concerns that certain products may appeal to...
Source: jdsupra.com